10.3390/microbiolres14030075 31 FakharianF.SadeghiA.PouresmaeiliF.SoleimaniN.YadegarA
Early failures underscored the complexity of ICH, whereas contemporary strategies emphasize antihypertensive therapy, neuroprotective and cytoprotective compounds, antioxidant and anti-inflammatory agents, ferroptosis inhibitors, multifunctional proteins such as HSA, and bioactive natural products
MT-1s clinical development as Afamelanotide for erythropoietic protoporphyria
Menzies AM, Johnson DB, Ramanujam S, Atkinson V, Wond ANM, Parker JJ, McQuade JL Shoushtari AN, Tsai KK, Eroglu Z, Klein O, Hassel JC, Sosman JA, Guminski A, Sullivan RJ, Ribas A, Carlin MS, Davies MA , Sandhu SK, Long GV
the feds do not demand that states ensure coverage